Archive for February, 2012

Breakfast in the shire: How is the UK reacting to Brüstle v Greenpeace?

Author: David Kent, 02/29/12

Last week I attended a breakfast at Eversheds, a law firm in Cambridge entitled Stem cell patenting, Brüstle v Greenpeace: business breaker or business as usual? which focused on the practical implications of the recent decision from the Court of Justice of the European Union on human embryonic stem (ES) cells. The event organizer, Adrian…Read more

Inside the Sauvageau lab

Author: Lisa Willemse, 02/10/12

One of the advantages of working in an admin office of an organization that funds stem cell research is that you tend to hear about what’s happening in labs all across the country. So when I heard that some interesting things were happening in the Guy Sauvageau lab, I decided to pay an overdue visit…Read more

News roundup: open access, new funding for personalized medicine and spinal cord injury update

Author: Lisa Willemse, 02/01/12

Some updates and news items of note: Call for boycott of subscriber-based journals gains momentum The ongoing friction between proponents of open access and the academic publishers has jumped into the spotlight once again with calls from a number of academics, most notably from prominent British mathmetician Tim Gowers, who publicly announced his decision to stop…Read more